ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,085Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 910

$972K Total Retail Price of All Prescriptions

Rank: 22 out of 910

975 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 975 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 975 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 17,409 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 1,250 1,214 1 3
LEVOTHYROXINE SODIUM 864 834 2 1
LISINOPRIL 861 768 3 2
AMLODIPINE BESYLATE 692 654 4 4
OMEPRAZOLE 546 503 5 5
METFORMIN HCL 526 474 6 6
ALENDRONATE SODIUM 456 438 7 22
GLIPIZIDE 410 366 8 38
HYDROCODONE-ACETAMINOPHEN 371 316 S3 9 8
ATENOLOL 363 340 10 10
METOPROLOL SUCCINATE 359 356 11 21
PANTOPRAZOLE SODIUM 350 317 12 27
WARFARIN SODIUM 344 314 13 11
LOSARTAN POTASSIUM 292 287 14 15
METOPROLOL TARTRATE 278 259 15 7
TRIAMTERENE-HCTZ 274 266 16 39
HYDROCHLOROTHIAZIDE 246 223 17 12
FLUTICASONE PROPIONATE 245 217 18 23
DOXAZOSIN MESYLATE 244 237 19 62
FLUOXETINE HCL 243 216 20 49
ZOLPIDEM TARTRATE 216 204 21 17
PRAVASTATIN SODIUM 197 182 22 16
ENALAPRIL MALEATE 195 191 23 60
TRAZODONE HCL 193 176 24 37
ATORVASTATIN CALCIUM 189 176 25 14
GABAPENTIN 182 169 26 13
FUROSEMIDE 179 159 27 9
LOVASTATIN 175 162 28 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 169 169 29 44
LIPITOR 142 122 30 97
FENOFIBRATE 141 111 31 55
DILTIAZEM ER 141 138 31 105
KLOR-CON 10 137 132 33 88
OXYCODONE-ACETAMINOPHEN 136 115 S2 34 31
POTASSIUM CHLORIDE 130 128 35 18
CLOPIDOGREL 127 119 36 35
TAMSULOSIN HCL 123 123 37 29
ADVAIR DISKUS 120 113 38 45
INSULIN SYRINGE 113 91 39 47
VENTOLIN HFA 108 82 40 208
DONEPEZIL HCL 106 106 41 32
CARVEDILOL 106 102 41 36
ALLOPURINOL 105 101 43 33
SERTRALINE HCL 105 96 43 24
PLAVIX 99 93 45 53
TERAZOSIN HCL 97 97 46 61
MORPHINE SULFATE ER 97 53 S2 46 52
RANITIDINE HCL 93 82 48 28
CITALOPRAM HBR 89 89 49 19
PAROXETINE HCL 89 89 49 50
DICLOFENAC SODIUM 88 79 51 116
CLONIDINE HCL 87 74 52 51
FINASTERIDE 86 86 53 59
CRESTOR 86 65 53 26
DIGOXIN 85 81 55 64
PREDNISONE 83 65 56 43
INDAPAMIDE 79 76 57 232
JANUVIA 79 76 57 69
SPIRONOLACTONE 79 72 57 66
OXYCODONE HCL 78 47 S2 60 42
LANTUS 77 61 61 30
ADACEL 73 66 62 248
NIFEDIAC CC 73 67 62 131
AMITRIPTYLINE HCL 72 60 R 64 72
DOXYCYCLINE HYCLATE 67 59 65 117
ESCITALOPRAM OXALATE 67 67 65 113
NADOLOL 66 63 67 211
OXYBUTYNIN CHLORIDE ER 66 58 67 111
CLONIDINE 65 53 69 264
BUPROPION HCL SR 65 55 69 157
TRAMADOL HCL 64 61 71 25
NAMENDA 63 63 72 57
ISOSORBIDE MONONITRATE ER 63 63 72 81
GALANTAMINE HBR 61 61 74 241
TRIAMTERENE-HYDROCHLOROTHIAZID 61 57 74 152
CYMBALTA 61 52 74 58
VERAPAMIL ER 61 58 74 99
ESTRADIOL 55 39 R 78 92
DIOVAN 54 54 79 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 50 80 134
KETOCONAZOLE 50 49 81 251
ZOSTAVAX 50 44 81 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.